Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.
《糖尿病》发表了有关糖尿病生理和病理生理学的原创研究。提交的手稿可以报告实验室、动物或人类研究的任何方面。重点是集中在糖尿病及其并发症的发病机制、正常和病理性胰岛功能和中间代谢、药物和激素作用的药理学机制以及正常和异常生物过程的生物化学和分子方面等领域的调查报告。糖尿病教育领域的研究或公认的治疗和诊断方法在糖尿病患者中的应用尚未发表。
AMPK and TBC1D1 Regulate Muscle Glucose Uptake After, but Not During, Exercise and Contraction
来源期刊：DiabetesDOI：10.2337/db19-0050
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
来源期刊：DiabetesDOI：10.2337/db19-0057
Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: A systematic review and meta‐analysis
来源期刊：DiabetesDOI：10.1111/dom.13828
Effectiveness of high‐intensity interval training combined with resistance training versus continuous moderate‐intensity training combined with resistance training in patients with type 2 diabetes: A one‐year randomized controlled trial
来源期刊：DiabetesDOI：10.1111/dom.13551
β-Cell–Derived Angiopoietin-1 Regulates Insulin Secretion and Glucose Homeostasis by Stabilizing the Islet Microenvironment
来源期刊：DiabetesDOI：10.2337/db18-0864
Microbiota-Produced N-Formyl Peptide fMLF Promotes Obesity-Induced Glucose Intolerance
来源期刊：DiabetesDOI：10.2337/db18-1307
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial
来源期刊：DiabetesDOI：10.1111/dom.13911
Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes
来源期刊：DiabetesDOI：10.1111/dom.13935
FDA guidance on cardiovascular risk of antidiabetic therapies: One decade later
来源期刊：DiabetesDOI：10.1111/dom.13669
174-LB: Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications
来源期刊：DiabetesDOI：10.2337/DB19-174-LB
389-P: Comparison of Hormonal Response to a Mixed-Meal Challenge in Individuals with Hypoglycemia after Sleeve Gastrectomy vs. Gastric Bypass
来源期刊：DiabetesDOI：10.2337/DB19-389-P
Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial
来源期刊：DiabetesDOI：10.1111/dom.13770
Persistent whole day meal effects of three dipeptidyl peptidase‐4 inhibitors on glycaemia and hormonal responses in metformin‐treated type 2 diabetes
来源期刊：DiabetesDOI：10.1111/dom.13934
1342-P: Development of Type 2 Diabetes (T2D) in Obese Adolescent Girls with Polycystic Ovary Syndrome (PCOS)
来源期刊：DiabetesDOI：10.2337/DB19-1342-P
News and Views July 2019
来源期刊：DiabetesDOI：10.1111/dom.13772
1186-P: Lean Women with Polycystic Ovary Syndrome and Insulin Resistance Have Normal Incretin Effect, which Is Unaffected by Metformin Therapy
来源期刊：DiabetesDOI：10.2337/DB19-1186-P
479-P: Combination of Trans-resveratrol and Hesperetin Corrects Unscheduled Increased Glucose Metabolism Driving Dysfunction of Human Periodontal Ligament Fibroblasts in Hyperglycemia In Vitro
来源期刊：DiabetesDOI：10.2337/db19-479-p
435-P: Elevated One-Hour Post-Challenge Glucose Levels Associated with Increased Arterial Stiffness
来源期刊：DiabetesDOI：10.2337/DB19-435-P
935-P: Identification of Characteristic Daily Glucose Excursions Associated with Triopathy in Adults with Type 1 Diabetes
来源期刊：DiabetesDOI：10.2337/DB19-935-P
1397-P: A Pregnancy Lifestyle Intervention Improves Metabolic Profile of Women and Infants by Reducing Gestational Weight Gain (GWG): The GLOW Randomized Controlled Trial
来源期刊：DiabetesDOI：10.2337/DB19-1397-P
2114-P: Use of Visceral Fat Area Measurement for Evaluating Obesity in Elderly Patients with Type 2 Diabetes
来源期刊：DiabetesDOI：10.2337/DB19-2114-P
242-OR: Do GLP-1RA and SGLT2i Reduce Cardiovascular Mortality in African-American Patients with Type 2 Diabetes? A Meta-analysis
来源期刊：DiabetesDOI：10.2337/DB19-242-OR
189-LB: Maternal Pharmacological Activation of PPAR-gamma or PPAR-alpha Differentially Affects Adiposity and Energy Metabolism in the Offspring of Rats Born to Mothers Subjected to Caloric Restriction during Pregnancy
来源期刊：DiabetesDOI：10.2337/DB19-189-LB
2388-PUB: App-Based Diabetes Management Plan: An Analogy between Diabetes Awareness and Plan Adoption
来源期刊：DiabetesDOI：10.2337/DB19-2388-PUB
1875-P: Liver-Specific p38 MAPK Stimulates Hepatic Fat Accumulation and Reduces Insulin Sensitivity In Vivo
来源期刊：DiabetesDOI：10.2337/DB19-1875-P
1205-P: Baseline Lactate Level Is a Useful Predictor for Weight Loss after Long-Term SGLT2 Inhibitor Treatment
来源期刊：DiabetesDOI：10.2337/DB19-1205-P
News and Views May 2019
来源期刊：DiabetesDOI：10.1111/dom.13709
2398-PUB: The Interplay of Type 1 Diabetes and Weight: A Qualitative Study of Thematic Progression with Age
来源期刊：DiabetesDOI：10.2337/DB19-2398-PUB
1275-P: Cost Effectiveness of Using DPP-4i and SGLT2i Combination Therapy vs. Switching to GLP-1 Therapy for the Management of Type 2 Diabetes
来源期刊：DiabetesDOI：10.2337/DB19-1275-P
2237-PUB: Validation of the Simple Diagnostic Criteria in Japan
来源期刊：DiabetesDOI：10.2337/DB19-2237-PUB
2070-P: Role of Education Attainment in Obesity: A Two-Sample Mendelian Randomization Study
来源期刊：DiabetesDOI：10.2337/DB19-2070-P
815-P: Eating Behaviors, Personality Traits, and Diabetes Fatalism: Predictors of HbA1c in Type 2 Diabetes
来源期刊：DiabetesDOI：10.2337/DB19-815-P
331-OR: Glycemic Index and Postprandial Blood Glucose Excursions, Insulin Requirements, and Hunger in T1D
来源期刊：DiabetesDOI：10.2337/DB19-331-OR
1119-P: Efficacy and Safety of Sitagliptin (SITA) Compared with Dapagliflozin (DAPA) in People ≥65 Years Old with T2D
来源期刊：DiabetesDOI：10.2337/DB19-1119-P
1108-P: The Total Basal Dose (TBD) Is about 35% of Total Daily Dose (TDD) and TBD/Weight Is about 0.23U/kg: 144 Subjects Titrated by Continuous Glucose Monitoring (CGM) while under Dietary Control
来源期刊：DiabetesDOI：10.2337/DB19-1108-P
1772-P: Insulin Granule Biogenesis at the Golgi Requires a Metabolically-Regulated, Non-centrosomal Subpopulation of Microtubules
来源期刊：DiabetesDOI：10.2337/DB19-1772-P
2263-PUB: Implementation of a Diabetes Self-Management Education (DSME) Program as Part of Discharge Counseling at a County Hospital
来源期刊：DiabetesDOI：10.2337/DB19-2263-PUB
1294-P: Detection and Intervention of Prediabetes in a Large Urban Health System: Systematic Failure or Looming Opportunity?
来源期刊：DiabetesDOI：10.2337/DB19-1294-P
152-LB: Sodium-Glucose Cotransporter Inhibitor Impairs Adhesion of Cancer Cells by Increasing Shedding and Dephosphorylation of Discoid Domain Receptor
来源期刊：DiabetesDOI：10.2337/DB19-152-LB
197-LB: Factors Associated with Screening for Diabetes in Low-Income Women after a Pregnancy with Gestational Diabetes
来源期刊：DiabetesDOI：10.2337/DB19-197-LB
97-LB: Point-of-Care HbA1c Testing in Redesign of Diabetes Management Program Lowered Costs and Improved Outcomes
来源期刊：DiabetesDOI：10.2337/DB19-97-LB
2354-PUB: Estimating Improvement of TGF Mechanism from Changes of Urinary Glucose and Sodium Excretion by SGLT2 Inhibitors
来源期刊：DiabetesDOI：10.2337/DB19-2354-PUB
115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes
来源期刊：DiabetesDOI：10.2337/DB19-115-LB
1548-P: High Prevalence of Glaucoma and Cataract with Uncommon Diabetic Retinopathy in Haitian Youth with Diabetes
来源期刊：DiabetesDOI：10.2337/DB19-1548-P
159-OR: Changes in Dairy Product Consumption and Risk of Type 2 Diabetes among U.S. Men and Women
来源期刊：DiabetesDOI：10.2337/DB19-159-OR
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors
来源期刊：DiabetesDOI：10.2337/db19-0097
738-P: Meta’omic Analysis of Elite Athletes Identifies a Performance-Enhancing Microbe that Functions via Lactate Metabolism
来源期刊：DiabetesDOI：10.2337/db19-738-p
1986-P: Hippocampal Overexpression of Triggering Receptor Expressed on Myeloid Cell 2 (TREM2) Ameliorates High-Fat Diet-Induced Neurocognitive Impairment via Modulating Microglial M1/M2 Polarization
来源期刊：DiabetesDOI：10.2337/DB19-1986-P
1647-P: High Serum YKL-40 Concentration Is Associated with One-Hour Post-Load Hyperglycemia
来源期刊：DiabetesDOI：10.2337/DB19-1647-P
1728-P: Inhibition of PKC-Theta in Prediabetic NOD Mice Prevents Diabetes Onset and Increases Regulatory CD4 T Cells in a Subset of Animals
来源期刊：DiabetesDOI：10.2337/DB19-1728-P
